- ►annals.org [PDF] JR Seibold, JH Korn, R Simms, PJ Clements, … - Annals of internal medicine, 2000 - Am Coll Physicians James R. Seibold, MD; Joseph H. Korn, MD; Robert Simms, MD; Phillip J. Clements,
MD, MPH; Larry W. Moreland, MD; Maureen D. Mayes, MD, MPH; Daniel E. Furst, MD;
Naomi Rothfield, MD; Virginia Steen, MD; Michael Weisman, MD; David ... Cited by 159 - Related articles - All 5 versions
PJ Clements, DE Furst, WK Wong, M Mayes, B … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 165 - Related articles - All 4 versions
CM Black, AJ Silman, AI Herrick, CP Denton … - Arthritis Care & Research - interscience.wiley.com In a randomized, placebo-controlled, double-blind trial, 35 patients with early
scleroderma received subcutaneous injections of either IFN (13.5 × 10 6 units
per week in divided doses) or indistinguishable placebo. Outcomes assessed ... Cited by 83 - Related articles - BL Direct - All 3 versions
JE Pope, N Bellamy, JR Seibold, M Baron, M … - Arthritis Care & Research - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 106 - Related articles - BL Direct - All 3 versions
- ►oxfordjournals.org [PDF] FHJ Van den Hoogen, AMT Boerbooms, AJG … - Rheumatology, 1996 - Br Soc Rheumatology In this study, methotrexate (MTX) was compared with placebo in the treatment of
systemic sclerosis (scleroderma, SSc) in a 24 week randomized double-blind
trial, followed by an observational trial of 24 weeks duration. Twenty-nine ... Cited by 95 - Related articles - BL Direct - All 5 versions
A Grassegger, G Schuler, G Hessenberger, B … - British Journal of Dermatology, 1998 - interscience.wiley.com We report the results of a randomized controlled multicentre study on
interferon-gamma (IFN-γ) treatment of systemic sclerosis as determined by skin
sclerosis, renal and other organ involvement, global assessment, subjective ... Cited by 68 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] JA Casas, PA Saway, I Villarreal, C Nolte, … - British Medical Journal, 1990 - ard.bmj.com Page 1. doi:10.1136/ard.49.11.926 1990;49;926-928 Ann Rheum Dis Blackburn,
GS Alarcón and CP Subauste JA Casas, PA Saway, I Villarreal ... Cited by 41 - Related articles - All 5 versions
DE Furst, PJ Clements, S Hillis, PA … - Arthritis Care & Research - interscience.wiley.com Placebo and chlorambucil (0.05-0.1 mg/kg/day) were compared as treatments for
scleroderma in a 3-year, randomized, double-blind, parallel study of 65
patients. Slopes of change over time, calculated for each organ system of ... Cited by 88 - Related articles - All 3 versions
SL Garber, Y Mirochnik, CS Brecklin, EN … - Kidney international, 2001 - nature.com Relaxin, a hormone of the insulin-growth factor family, promotes collagen
remodeling. In rodent models of pulmonary and dermal fibrosis, relaxin reduced
interstitial fibrosis. To study relaxin's effect in renal disease, we used ... Cited by 89 - Related articles - BL Direct - All 5 versions
M Dziadzio, CP Denton, R Smith, K Howell, A … - Arthritis Care & Research - interscience.wiley.com In a randomized, parallel-group, controlled trial, patients with primary RP (n =
25) or RP secondary to systemic sclerosis (SSc [scleroderma]; n = 27) were
allocated to receive 12 weeks' treatment with either losartan (50 mg/day) ... Cited by 129 - Related articles - All 4 versions
